Advertisement
Screener

SOLENO THERAPEUTICS INC Interest Expense

SOLENO THERAPEUTICS INC Interest Expense

SOLENO THERAPEUTICS INC reported Interest Expense of $0 for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-14.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2016-11-14

  • SOLENO THERAPEUTICS INC interest expense for the quarter ending 2016-09-30 was $0.00.
  • SOLENO THERAPEUTICS INC interest expense for the quarter ending 2016-06-30 was $0.00.
  • SOLENO THERAPEUTICS INC interest expense for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
  • SOLENO THERAPEUTICS INC interest expense for the quarter ending 2015-12-31 was -$1.00K, a 100.04% decline year-over-year.
  • SOLENO THERAPEUTICS INC interest expense for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
  • SOLENO THERAPEUTICS INC interest expense for fiscal 2014 was $4.13M, a 44.41% increase from fiscal 2013.
  • SOLENO THERAPEUTICS INC interest expense for fiscal 2013 was $2.86M.
Period endInterest Expense 3 monthInterest Expense 6 monthInterest Expense 9 monthInterest Expense 9 month as first filedInterest Expense 12 month
2016-09-30$0.00
10-Q · filed 2016-11-14
$0.00
derived: sum of 2 quarters · filed 2016-11-14
$0.00
10-Q · filed 2016-11-14
-$1.00K
derived: sum of 4 quarters · filed 2016-11-14
2016-06-30$0.00
10-Q · filed 2016-08-12
$0.00
10-Q · filed 2016-08-12
-$1.00K
derived: sum of 3 quarters · filed 2016-08-12
-$1.00K
derived: sum of 4 quarters · filed 2016-11-14
2016-03-31$0.00
10-Q · filed 2016-08-09
-$1.00K
derived: sum of 2 quarters · filed 2016-08-09
-$1.00K
derived: sum of 3 quarters · filed 2016-11-14
-$1.00K
derived: sum of 4 quarters · filed 2016-11-14
2015-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25
-$1.00K
derived: sum of 2 quarters · filed 2016-11-14
-$1.00K
derived: sum of 3 quarters · filed 2016-11-14
$0.00
10-K · filed 2016-03-25
2015-09-30$0.00
10-Q · filed 2016-11-14
$0.00
derived: sum of 2 quarters · filed 2016-11-14
$1.00K
10-Q · filed 2016-11-14
$2.32M
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$0.00
10-Q · filed 2016-08-12
$1.00K
10-Q · filed 2016-08-12
$2.32M
derived: sum of 3 quarters · filed 2016-08-12
$3.07M
derived: sum of 4 quarters · filed 2016-08-12
2015-03-31$1.00K
10-Q · filed 2016-08-09
$2.32M
derived: sum of 2 quarters · filed 2016-08-09
$3.07M
derived: sum of 3 quarters · filed 2016-08-09
$3.74M
derived: sum of 4 quarters · filed 2016-08-09
2014-12-31$2.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25
$3.07M
derived: sum of 2 quarters · filed 2016-03-25
$3.74M
derived: sum of 3 quarters · filed 2016-03-25
$4.13M
10-K · filed 2016-03-25
2014-09-30$752.00K
10-Q · filed 2015-11-12
$1.42M
derived: sum of 2 quarters · filed 2015-11-12
$1.81M
10-Q · filed 2015-11-12
$1.81M
10-Q · filed 2014-12-18
$2.12M
derived: sum of 4 quarters · filed 2015-11-12
2014-06-30$670.00K
10-Q · filed 2015-08-10
$1.06M
10-Q · filed 2015-08-10
$1.37M
derived: sum of 3 quarters · filed 2015-08-10
$1.94M
derived: sum of 4 quarters · filed 2015-08-10
2014-03-31$388.00K
10-Q · filed 2015-05-04
$698.27K
derived: sum of 2 quarters · filed 2015-05-04
$1.27M
derived: sum of 3 quarters · filed 2015-05-04
2013-12-31$310.27K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13
$881.27K
derived: sum of 2 quarters · filed 2015-03-13
$2.86M
10-K · filed 2015-03-13
2013-09-30$571.00K
10-Q · filed 2014-12-18
$2.55M
10-Q · filed 2014-12-18